微阵列市场规模、份额、成长分析，按产品/服务、类型、应用、最终用途、地区 - 产业预测，2024-2031

2022年全球微阵列市场规模为51亿美元，从2023年的54.9亿美元成长到2031年的99.4亿美元，复合年增长率预计为7.7%。

微阵列技术在基因组学领域发挥着重要作用，透过将大量核酸附着在表面上，透过杂合反应来测量相对核酸序列浓度。这种创新方法与染色质免疫沉淀分析法相结合，对于定量基因表现水平和识别转录因子结合位点特别有用。作为为生物学家提供丰富而复杂的数位资料的首批技术之一，微阵列继续发挥重要作用。特别是，随着原始资料和处理数据的出现，它们的重要性日益增加，这些数据支持广泛的分析和荟萃分析。功能基因组学数据协会制定的 MIAME 标准将确保微阵列研究的高品质和一致报告，最终推动未来预测期内对微阵列技术的需求。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

微阵列市场规模：依产品/服务及复合年增长率（2024-2031）

• 市场概况
• 消耗品
• 装置
• 软体和服务

微阵列市场规模：按类型和复合年增长率（2024-2031）

• 市场概况
• DNA微阵列
• 蛋白质微阵列
• 其他的

微阵列市场规模：依应用与复合年增长率（2024-2031）

• 市场概况
• 研究用途
• 药物发现
• 疾病诊断
• 其他用途

微阵列市场规模：依最终用途和复合年增长率（2024-2031）

• 市场概况
• 研究/学术机构
• 製药和生物技术公司
• 诊断实验室

微阵列市场规模：按地区和复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Illumina, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Thermo Fisher Scientific, Inc.（USA）
• Merck KGaA（Germany）
• PerkinElmer, Inc.（USA）
• Arrayit Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• GE Healthcare（UK）
• Molecular Devices, LLC.（USA）
• Affymetrix（USA）
• RayBiotech Life, Inc.（USA）
• Full Moon BioSystem, Inc.（USA）
• CapitalBio Technology Co., Ltd.（China）
• Microarray Inc.（USA）
• QIAGEN（Netherlands）
• Roche NimbleGen（USA）
• Applied Microarrays（USA）
• bioMerieux SA（France）
• Discerna（USA）
• Gyros AB（Sweden）

结论和建议

Global Microarray Market size was valued at USD 5.1 billion in 2022 and is poised to grow from USD 5.49 billion in 2023 to USD 9.94 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2024-2031).

Microarray technology remains pivotal in the genomics landscape, allowing for the binding of numerous nucleic acids to a surface, which facilitates the measurement of relative nucleic acid sequence concentrations through hybridization. This innovative approach is particularly valuable for quantifying gene expression levels and pinpointing transcription factor binding sites when paired with chromatin immunoprecipitation. As one of the earliest technologies offering biologists a wealth of complex digital data, microarrays continue to play a crucial role, especially with the advent of raw and processed data that supports extensive analysis and meta-analyses. The MIAME standards established by the Function Genomics Data Society ensure high-quality, consistent reporting in microarray research, ultimately driving demand for microarray technology in the upcoming forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microarray market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microarray Market Segmental Analysis

Global Microarray Market is segmented by product and services, type, application, end use and region. Based on product and services, the market is segmented into consumables, instruments and software and services. Based on type, the market is segmented into DNA microarray, protein microarray and others. Based on application, the market is segmented into research applications, drug discovery, disease diagnostics and others applications. Based on end use, the market is segmented into research and academic institutes, pharmaceutical and biotechnology companies and diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microarray Market

Global Microarray is a cutting-edge technology designed for high-throughput analysis of gene expression, enabling researchers to investigate the complexities of genomic data rapidly and efficiently. This driver provides an interface for seamless integration with existing bioinformatics pipelines, allowing users to preprocess, analyze, and visualize microarray data effortlessly. With its intuitive functionality, users can easily load raw data, apply normalization techniques, perform differential expression analysis, and generate insightful visualizations such as heatmaps and volcano plots. Furthermore, the driver supports various data formats and harmonizes with popular statistical packages, ensuring compatibility and fostering reproducibility in genetic research and clinical studies.

Restraints in the Global Microarray Market

Global Microarray is a powerful biotechnology company leveraging cutting-edge microarray technology for genomic analysis. However, its expansion is restrained by several factors, including regulatory hurdles associated with genetic testing and data privacy concerns. Furthermore, the high cost of microarray technology can limit accessibility for smaller laboratories and institutions, potentially stifling research innovation. The competitive landscape, with rapid advancements in alternative genomic sequencing technologies, poses an additional challenge to maintaining market leadership. Lastly, the reliance on skilled personnel and specialized training necessitates a continuous investment in human resources, which can strain operational budgets and affect long-term sustainability.

Market Trends of the Global Microarray Market

The global microarray market is experiencing dynamic trends driven by the need for personalized medicine and precision diagnostics. As the demand for genetic analysis and profiling escalates, advancements in genomics research and understanding of genetic variations are propelling microarray technology to the forefront. Additionally, the industry is witnessing a significant shift toward multiplexing and high-throughput analysis, allowing researchers to evaluate thousands of genes or proteins simultaneously, thereby enhancing efficiency and reducing costs. Furthermore, the focus on biomarker discovery and validation is intensifying, as microarrays play a crucial role in identifying potential biomarkers for early disease detection and targeted therapies, further propelling market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Microarray Market Size by Product and Services & CAGR (2024-2031)

• Market Overview
• Consumables
• Instruments
• Software and Services

Global Microarray Market Size by Type & CAGR (2024-2031)

• Market Overview
• DNA Microarray
• Protein Microarray
• Others

Global Microarray Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
• Drug Discovery
• Disease Diagnostics
• Others Applications

Global Microarray Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories

Global Microarray Market Size & CAGR (2024-2031)

• North America (Product and Services, Type, Application, End Use)
  • USA
  • Canada
• Europe (Product and Services, Type, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product and Services, Type, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product and Services, Type, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product and Services, Type, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arrayit Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Life, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Full Moon BioSystem, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapitalBio Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microarray Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche NimbleGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Microarrays (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Discerna (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gyros AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations